Agrylin Drug Use-Result Survey

Clinical trial NCT03625895 · COMPLETED

Trial details

NCT number: NCT03625895
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Essential Thrombocythemia (ET)

Start date: 2014-11-25
Primary completion: 2021-03-11
Enrollment: 1826

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.